Led by John Buse, MD, PhD, and Anna Kahkoska, MD, PhD, this analysis showed that GLP1-RA and SGLT2i medication use for type 2 diabetes of hospitalized COVID-19 patients was associated…
NC State researchers led by Ke Cheng, PhD, created a therapeutic approach that mimics the receptor that the virus binds to and then traps the virus before it infect cells….
James F. Howard Jr., MD, Distinguished Professor in the UNC Department of Neurology, was principal investigator of the promising phase 3 trial for the experimental drug efgartigimod.
Scientists led by UNC School of Medicine researchers Silvia Kreda, PhD, and Rudolph Juliano, PhD, created an improved oligonucleotide therapy strategy with the potential for treating other pulmonary diseases, such…
This pre-clinical research offers evidence that vaccinating young children could help prevent the spread of COVID-19, limit disease severity, and achieve herd immunity.
The UNC School of Medicine lab of Mehmet Kesimer, PhD, discovered MUC5AC is more reliably associated with the manifestation of COPD than another well-known mucus protein, revealing a possible biomarker…
The UNC School of Medicine labs of Pengda Liu, PhD, and Guochun Jiang, PhD, led work to show how the drug lenalidomide can disrupt the pseudo-coronavirus’s ability to infect human…
UNC-Chapel Hill and Duke researchers promote better health through gamification. The study was co-led by Lisa Hightow-Weidman, MD, MPH, at the UNC School of Medicine, and Kate Meussig, Phd, at…
UNC School of Medicine’s David Peden, MD, is the UNC site principal investigator of the NIH-sponsored study, and Scott Commins, MD, PhD, is co-PI. Participants can now enroll at UNC-Chapel…
UNC-Chapel Hill scientists discovered microRNA-29 is an important cellular switch controlling late-stage brain development, a foundational discovery that will help researchers explore new therapeutic approaches for neurodevelopmental conditions.
Participating households in Greenville, Pitt County, NC will receive free month-long supplies of rapid tests aimed at reducing community transmission of COVID-19. UNC School of Medicine’s Giselle Corbie-Smith, MD, and…
Research from the UNC School of Medicine lab of Jenny Ting, PhD, shows that the widely used drug metformin reduces metabolism of infected T cells to suppress HIV replication.
A pilot study from researchers at NC State and UNC school of Medicine shows evidence of Bartonella infection in the blood of people with schizophrenia and schizoaffective disorder. Flavio Frohlich,…
Researchers in the UNC School of Medicine Lab of Thomas Kash, PhD, published new findings in the journal Neuron showing how neurons in two brain regions use dopamine to promote…
A study led by Muneera Kapadia, MD, associate professor of surgery in the UNC School of Medicine, is the first to examine the effect of a surgeon’s mask on communication…
The findings reported on a secondary objective to reduce time to negative test result of infectious SARS-CoV-2 virus in individuals with symptomatic COVID-19. UNC School of Medicine’s William Fischer, MD,…
The discovery, from the UNC School of Medicine lab of Mark Zylka, PhD, offers pain researchers a new, precise target to treat inflammation associated with neuropathic pain.
First-year college students are reporting symptoms of depression and anxiety significantly more often than they were before the coronavirus pandemic, according to a study co-authored by Krista Perreira, PhD, professor…
UNC-Chapel Hill scientists Charles Carter, Qi Zhang, and Abigail Knight were awarded $1 million from the W.M. Keck Foundation to answer the age-old question: How did life on Earth begin?
UNC-Chapel Hill research, led by Allison Aiello, PhD, and Emily Ciccone, MD, shows that individuals previously infected with SARS-CoV-2 develop a significant antibody response to the first dose of mRNA-based…
